Opportunity
Federal Register #2026-21883
NRC Seeks Interventional Radiologist for Isotopes Advisory Committee
Buyer
Nuclear Regulatory Commission
Posted
October 27, 2026
Respond By
December 29, 2026
Identifier
2026-21883
NAICS
621111
The U.S. Nuclear Regulatory Commission is seeking an interventional radiologist to advise its Advisory Committee on the Medical Uses of Isotopes. - Government buyer: U.S. Nuclear Regulatory Commission (NRC), Office of Nuclear Material Safety and Safeguards. - Requested service: One interventional radiologist committee membership providing advice on NRC matters involving medical uses of byproduct material. - Topics include proposed rules and guidance, training and experience requirements, medical events, non-routine uses, and issues affecting the interventional radiology community. - Candidate requirements: Nominees must be practicing interventional radiologists and U.S. citizens, and be available for approximately 160 hours of committee work per year. - Term and participation: Four-year term, with possible consideration for one additional term; members participate in semiannual virtual meetings and other meetings as needed. - Products and OEMs: No products, part numbers, quantities of goods, or OEMs are identified. - Other named company: The attachment also refers to Cboe Clear U.S., LLC in a separate SEC registration notice; it is unrelated to the NRC committee membership and is not a procurement requirement.
Description
The U.S. Nuclear Regulatory Commission is soliciting nominations for an Interventional Radiologist position on the Advisory Committee on the Medical Uses of Isotopes (ACMUI). Nominees must currently practice as an Interventional Radiologist, be U.S. citizens, and be able to devote approximately 160 hours per year to committee business. The position advises the NRC on regulation and other issues related to interventional radiology applications of byproduct material. Nominations, including a resume or curriculum vitae and cover letter, are due on or before December 28, 2026.